2025-10-24T10:17:55-05:00 2024-12-31 420714325 RSM US LLP 7351 OFFICE PARK PLACE MELBOURNE FL 329408229 990 2024-01-01 274313833 IAS IAS 4438070412 PO BOX 65494 WASHINGTON DC 20035 EMMANUEL FLAMAND SECRETARY 4438070412 2025-10-22 1 1 KELLI PECK P01423033 3217516200 2025-10-22 2024 2025-03-06 01:10:19Z CHRIS BEYRER PO BOX 65494 WASHINGTON DC 20035 2791572 0 X HTTPS://WWW.IASOCIETY.ORG/ X 2010 DC THE CORPORATION IS ORGANIZED FOR CHARITABLE AND EDUCATIONAL PURPOSES, INCLUDING: (I) PROVIDING CRITICAL PLATFORMS FOR PRESENTING NEW RESEARCH, SHARING BEST PRACTICES, AND ADVANCING THE FIGHT AGAINST AIDS; AND (II) PROMOTING DIALOGUES, EDUCATION, AND NETWORKING TO HELP CLOSE GAPS IN KNOWLEDGE AND EXPERTISE AT EVERY LEVEL OF THE RESPONSE TO AIDS. 4 2 0 146 0 0 870000 2500000 13277 0 434754 291572 0 0 1318031 2791572 37250 246000 0 0 15698 0 0 0 0 798445 2167670 851393 2413670 466638 377902 10572849 11312751 9098053 9460053 1474796 1852698 X TO PROVIDE CRITICAL PLATFORMS FOR PRESENTING NEW RESEARCH, SHARING BEST PRACTICES AND ADVANCING THE FIGHT AGAINST AIDS AND PROMOTING DIALOGUE, EDUCATION AND NETWORKING TO HELP CLOSE GAPS IN KNOWLEDGE AND EXPERTISE AT EVERY LEVEL OF THE RESPONSE TO AIDS. 0 0 900000 150120 AIDS 2024, THE 25TH INTERNATIONAL AIDS CONFERENCE, TOOK PLACE IN MUNICH, GERMANY, AND VIRTUALLY, ON 22-26 JULY 2024, WITH OVER 10,000 PARTICIPANTS FROM 169 COUNTRIES. SEVEN PERCENT HAD VIRTUAL REGISTRATIONS, ALLOWING THEM TO VIEW LIVE SESSIONS, ASK QUESTIONS AND NETWORK WITH OTHER DELEGATES ONLINE. AT AIDS 2024, DELEGATES HEARD THAT SIX-MONTHLY INJECTIONS OF LENACAPAVIR GAVE 100% PROTECTION AGAINST HIV ACQUISITION IN CISGENDER WOMEN IN THE PURPOSE-1 STUDY. DELEGATES GAVE THE PURPOSE-1 STUDY TEAM A STANDING OVATION, RECOGNIZING A MAJOR ADVANCE IN HIV PREVENTION. THE CONFERENCE FEATURED 40 ORAL ABSTRACT SESSIONS ORGANIZED INTO SIX TRACKS. THE 50 INVITED-SPEAKER SESSIONS WERE MADE UP OF FIVE PLENARIES, FOUR SPECIAL SESSIONS AND 41 SYMPOSIA. TWENTY-TWO WORKSHOPS, 17 PRE-CONFERENCES AND 115 SATELLITE SESSIONS COMPLEMENTED THE INVITED-SPEAKER AND ABSTRACT-DRIVEN PROGRAMME. A TOTAL OF 7,260 ABSTRACTS WERE SUBMITTED TO AIDS 2024, INCLUDING 581 LATE-BREAKER ABSTRACTS. ULTIMATELY, 2,772 ABSTRACTS WERE SELECTED FOR PRESENTATION IN SESSIONS AND THE POSTER EXHIBITION, AN ACCEPTANCE RATE OF 38%. 1400000 95880 HIVR4P 2024, THE 5TH HIV RESEARCH FOR PREVENTION CONFERENCE, TOOK PLACE IN LIMA, PERU, AND VIRTUALLY FROM 7 TO 10 OCTOBER 2024. JUST UNDER 1,400 PARTICIPANTS FROM 77 COUNTRIES GATHERED FOR FOUR DAYS TO REVIEW THE LATEST ADVANCES IN HIV PREVENTION SCIENCE. THE HIV RESEARCH FOR PREVENTION CONFERENCE IS THE ONLY GLOBAL SCIENTIFIC CONFERENCE FOCUSED EXCLUSIVELY ON THE CHALLENGING AND FAST-GROWING FIELD OF HIV PREVENTION RESEARCH. THIS CONFERENCE FOSTERS INTERDISCIPLINARY KNOWLEDGE EXCHANGE ON HIV VACCINES, MICROBICIDES, PREP, TREATMENT AS PREVENTION AND BIOMEDICAL INTERVENTIONS, AS WELL AS THEIR SOCIAL AND BEHAVIOURAL IMPLICATIONS. AT HIVR4P 2024, RESULTS FROM PURPOSE 2 SHOWED THAT INJECTABLE LENACAPAVIR LONG[1]ACTING PRE-EXPOSURE PROPHYLAXIS (PREP) WAS HIGHLY EFFECTIVE IN PREVENTING HIV ACQUISITION IN MEN WHO HAVE SEX WITH MEN AND TRANS WOMEN. RESEARCHERS SUBMITTED A TOTAL OF 1,740 ABSTRACTS TO HIVR4P 2024 (1,548 REGULAR ABSTRACTS AND 192 LATE-BREAKER ABSTRACTS) AND 827 WERE ACCEPTED FOR PRESENTATION, INCLUDING 127 ORAL ABSTRACTS, 21 LATE-BREAKING ORAL ABSTRACTS, 280 POSTER ABSTRACTS AND 399 E-POSTER ABSTRACTS. RESEARCH WAS PRESENTED IN 16 INVITED-SPEAKER SESSIONS, 26 ORAL ABSTRACT SESSIONS AND 26 SATELLITES. 2300000 1 1 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 0 0 0 1 0 1 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 2 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 X 4 2 0 0 0 0 1 1 1 1 1 0 0 0 1 1 1 0 0 0 0 0 DC X THE ORGANIZATION 4438070412 PO BOX 65494 WASHINGTON DC 20035 CHRIS BEYRER MD MPH PRESIDENT 0.10 0.10 X X 0 0 0 MITCHELL WARREN VICE PRESIDENT 0.10 0.10 X X 0 0 0 JENIFER KATES TREASURER (THRU 7/23/24) 0.10 0.10 X X 0 0 0 CAROLE BEILEAU TREASURER 0.10 40.00 X X 0 176684 0 EMMANUEL FLAMAND SECRETARY 0.80 40.00 X X 0 204806 0 BIRGIT PONIATOWSKI EXECUTIVE DIRECTOR 0.60 40.00 X 0 280877 0 0 662367 0 3 0 1 0 0 2300000 200000 2500000 291572 291572 2791572 0 0 291572 X 32110 32110 213890 213890 1354 1354 39151 39151 245818 245818 190137 190137 1463 1463 1296439 1296439 EQUIPMENT LEASING 320143 320143 INDIRECT COST 69000 69000 BANK FEE 4165 4165 2413670 2300000 113670 0 412869 157872 10124658 9707537 1410000 35322 35322 2020 10572849 11312751 50000 43000 9048053 9417053 9098053 9460053 X 1318411 1626313 156385 226385 1474796 1852698 10572849 11312751 377902 0 X 0 1 X 0 1 1 X 9010110 1646950 1164000 870000 2500000 15191060 9010110 1646950 1164000 870000 2500000 15191060 361254 14829806 28218 15381 132678 434754 291572 902603 16093663 797223 0.92150 0.92130 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 DUE TO INT'L AIDS SOCIETY 9417053 9417053 X 2791572 0 2791572 0 2791572 2413670 0 2413670 0 2413670 PART X, LINE 2: IAS REQUIRES THAT A TAX POSITION BE RECOGNIZED OR DERECOGNIZED BASED ON A "MORE-LIKELY-THAN-NOT" THRESHOLD. THIS APPLIES TO POSITIONS TAKEN IN A TAX RETURN. IAS DOES NOT BELIEVE ITS FINANCIAL STATEMENTS INCLUDE, OR REFLECT, ANY UNCERTAIN TAX POSITIONS. IAS'S FORM 990, RETURN OF ORGANIZATION EXEMPT FROM INCOME TAX, IS SUBJECT TO EXAMINATION BY THE TAXING AUTHORITIES GENERALLY FOR THREE YEARS AFTER FILING. 1 SOUTH AMERICA 0 0 PROGRAM SERVICES CONFERENCE SUPPORT 695698 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 PROGRAM SERVICES CONFERENCE SUPPORT 1244251 CENTRAL AMERICA AND THE CARIBBEAN 0 0 GRANTMAKING 8145 EAST ASIA AND THE PACIFIC 0 0 GRANTMAKING 22930 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 GRANTMAKING 20525 MIDDLE EAST AND NORTH AFRICA 0 0 GRANTMAKING 3915 NORTH AMERICA 0 0 GRANTMAKING 10915 RUSSIA AND NEIGHBORING STATES 0 0 GRANTMAKING 10970 SOUTH ASIA 0 0 GRANTMAKING 14900 SOUTH AMERICA 0 0 GRANTMAKING 21050 SUB-SAHARAN AFRICA 0 0 GRANTMAKING 100540 0 0 0 0 0 0 2017349 136490 2153839 HIV R4P SCHOLARSHIP CENTRAL AMERICA AND THE CARIBBEAN 3 1470 WIRE TRANSFER HIV R4P SCHOLARSHIP EAST ASIA AND THE PACIFIC 9 3720 WIRE TRANSFER HIV R4P SCHOLARSHIP EUROPE (INCLUDING ICELAND & GREENLAND) 9 3550 WIRE TRANSFER HIV R4P SCHOLARSHIP MIDDLE EAST AND NORTH AFRICA 3 1200 WIRE TRANSFER HIV R4P SCHOLARSHIP NORTH AMERICA 7 2590 WIRE TRANSFER HIV R4P SCHOLARSHIP RUSSIA AND NEIGHBORING STATES 5 1610 WIRE TRANSFER HIV R4P SCHOLARSHIP SOUTH ASIA 11 4480 WIRE TRANSFER HIV R4P SCHOLARSHIP SOUTH AMERICA 23 9420 WIRE TRANSFER HIV R4P SCHOLARSHIP SUB-SAHARAN AFRICA 110 49720 WIRE TRANSFER 2024 AID CONFERENCE CENTRAL AMERICA AND THE CARIBBEAN 12 6675 WIRE TRANSFER 2024 AID CONFERENCE EAST ASIA AND THE PACIFIC 35 19210 WIRE TRANSFER 2024 AID CONFERENCE EUROPE (INCLUDING ICELAND & GREENLAND) 32 16975 WIRE TRANSFER 2024 AID CONFERENCE MIDDLE EAST AND NORTH AFRICA 5 2715 WIRE TRANSFER 2024 AID CONFERENCE NORTH AMERICA 15 8325 WIRE TRANSFER 2024 AID CONFERENCE RUSSIA AND NEIGHBORING STATES 17 9360 WIRE TRANSFER 2024 AID CONFERENCE SOUTH AMERICA 19 10420 WIRE TRANSFER 2024 AID CONFERENCE SOUTH ASIA 22 11630 WIRE TRANSFER 2024 AID CONFERENCE SUB-SAHARAN AFRICA 94 50820 WIRE TRANSFER 0 0 0 0 0 0 PART I, LINE 2: THE BUDGETING AND GRANT RESTRICTIONS ARE REPORTED TO A P&L OWNER THROUGH AN INTERNAL FORM IN THE BEGINNING OF THE GRANT CIRCLE. THE 4 EYES PRINCIPLE IS USED, AND AUTHORITY IS GIVEN TO A LIMITED AMOUNT OF STAFF. RFPS ARE MANDATORY FOR AMOUNTS ABOVE $20K. EXPENDITURES MUST BE SUPPORTED WITH ADEQUATE DOCUMENTATION AND APPROVAL OR THE PAYMENT IS REJECTED. IAS HAS REGULAR INTERNAL REPORTING AND ONLINE SYSTEM MONOTORING, AN ANNUAL AUDIT, AND REPORTS TO DONORS. PART III, COL (C): USED TOTAL AMOUNT PER REGION AND AVERAGE SCHOLARSHIP AMOUNT 1 2024 AID CONFERENCE 22 13990 HIV R4P CONFERENCE 35 18120 PART I, LINE 2: THE BUDGETING AND GRANT RESTRICTIONS ARE REPORTED TO A P&L OWNER THROUGH AN INTERNAL FORM IN THE BEGINNING OF THE GRANT CIRCLE. THE 4 EYES PRINCIPLE IS USED, AND AUTHORITY IS GIVEN TO A LIMITED AMOUNT OF STAFF. RFPS ARE MANDATORY FOR AMOUNTS ABOVE $20K. EXPENDITURES MUST BE SUPPORTED WITH ADEQUATE DOCUMENTATION AND APPROVAL OR THE PAYMENT IS REJECTED. IAS HAS REGULAR INTERNAL REPORTING AND ONLINE SYSTEM MONITORING, AN ANNUAL AUDIT, AND REPORTS TO DONORS. 0 0 0 0 0 0 0 0 0 BIRGIT PONIATOWSKI EXECUTIVE DIRECTOR 0 280877 0 0 0 0 0 0 0 0 0 280877 0 0 EMMANUEL FLAMAND SECRETARY 0 204806 0 0 0 0 0 0 0 0 0 204806 0 0 CAROLE BEILEAU TREASURER 0 176684 0 0 0 0 0 0 0 0 0 176684 0 0 FORM 990, PART VI, SECTION A, LINE 6 THE INTERNATIONAL AIDS SOCIETY BASED IN GENEVA, SWITZERLAND, IS THE SINGLE VOTING MEMBER OF IAS. FORM 990, PART VI, SECTION A, LINE 7A THE MEMBER SHALL HAVE THE POWER TO APPOINT AND REMOVE DIRECTORS OF THE GOVERNING BODY. FORM 990, PART VI, SECTION A, LINE 7B THE MEMBER SHALL HAVE THE RIGHT TO APPROVE AMENDMENTS TO THE ARTICLES AND BYLAWS OF THE CORPORATION, AS WELL AS TO APPROVE MAJOR CORPORATE CHANGES SUCH AS DISSOLUTION, MERGER, REORGANIZATION, OR TRANSFER OF ALL OR SUBSTANTIALLY ALL OF THE CORPORATION'S ASSETS. FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 WAS NOT SENT TO THE GOVERNING BODY. THE CHAIR RECEIVES A COPY FOR REFERENCE VIA EMAIL. FORM 990, PART VI, SECTION B, LINE 12C EACH DIRECTOR, PRINCIPAL OFFICER, AND ALL IAS STAFF MUST ANNUALLY SIGN A STATEMENT THAT AFFIRMS SUCH PERSON: -HAS RECEIVED A COPY OF THE CONFLICTS OF INTEREST POLICY; -HAS READ AND UNDERSTANDS THE POLICY; -HAS AGREED TO COMPLY WITH THE POLICY; AND -UNDERSTANDS IAS IS CHARITABLE AND IN ORDER TO MAINTAIN ITS FEDERAL TAX EXEMPTION IT MUST ENGAGE PRIMARILY IN ACTIVITIES THAT ACCOMPLISH ONE OR MORE OF ITS TAX-EXEMPT PURPOSES. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION'S GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE NOT TYPICALLY MADE AVAILABLE TO THE PUBLIC UNLESS UPON REQUEST. FORM 990, PART IX, LINE 11G CONSULTANT FEES: PROGRAM SERVICE EXPENSES 245,818. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 245,818. INTERNATIONAL AIDS SOCIETY AVENUE DE FRANCE 23 GENEVA SZ CH-1202 TO IMPROVE THE TREATMENT, CARE AND QUALITY OF LIFE FOR PEOPLE WITH HIV SZ 501(C)(3) N/A 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 1 0 0 0 0 INTERNATIONAL AIDS SOCIETY E 9417053 FMV